Skip to main content

Angela Vidal Jordana

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Angela Vidal Jordana

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Incorporació Dr. Manuel Comabella a la RETICS en Esclerosis Múltiple

IP: Manuel Comabella Lopez
Collaborators: Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Herena Eixarch Ahufinger, Incorporació Dr. Manuel Comabella a la RETICS en Esclerosis Múltiple, Carmen Espejo Ruiz, Angela Vidal Jordana, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 225500
Reference: RD16/0015/0004
Duration: 01/01/2017 - 31/12/2022

Sol·licitud Juan Rodés

IP: Sol·licitud Juan Rodés
Collaborators: Angela Vidal Jordana, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 135000
Reference: JR16/00024
Duration: 01/01/2017 - 21/04/2020

(BiomarkEM.cat) New technologies applied to clinical practice for obtaining biomarkers of atrophy and lesions in magnetic resonance images of patients with multiple sclerosis

IP: Jordi Rio Izquierdo
Collaborators: Jaume Sastre Garriga, Cristina Auger Acosta, Deborah Pareto Onghena, Alex Rovira Cañellas, Angela Vidal Jordana
Funding agency: Fundació La Marató de TV3
Funding: 95181.33
Reference: 20142531
Duration: 10/03/2015 - 21/05/2019

Diagnostic and prognostic biomarkers in pediatric multiple sclerosis and related demyelinating disorders

IP: Mar Tintore Subirana
Collaborators: Cristina Auger Acosta, Georgina Arrambide García, Alex Rovira Cañellas, Mireia Del Toro Riera, Angela Vidal Jordana, Luciana Midaglia Fernandez
Funding agency: Fundació La Marató de TV3
Funding: 100000
Reference: 20141831
Duration: 22/05/2015 - 22/11/2018

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Ma Luisa Navarrete Álvaro

Ma Luisa Navarrete Álvaro

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Claudia Rosanella Caamaño

Claudia Rosanella Caamaño

Research technician
Molecular Imaging and Therapy
Read more
Irene Porta Bravo

Irene Porta Bravo

Research assistant
Headache and Neurological Pain
Read more
Elba Molpeceres Sierra

Elba Molpeceres Sierra

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.